Discovery Life Sciences™ has announced two major European acquisitions including Sofia Bio and its extensive network of human biospecimen collection sites in Bulgaria, Czechia, Poland and Romania. Discovery has also entered into an agreement to become the exclusive industry distributor of East West Biopharma, which maintains the largest biocollection network in Ukraine.
Discovery Life Sciences, founded in 2004 with primary locations in California, Ohio, and Alabama, USA, is a global market leader in biospecimen analysis and procurement for the pharmaceutical, biotechnology, and diagnostics industries. Driven by science, the Discovery team engages with customers in an innovative, consultative approach to overcoming obstacles and reaching a faster end result.
The new European acquisitions cement Discovery’s position as the global leader in biospecimen analysis, procurement, and distribution for the pharmaceutical, biotechnology, and diagnostics industries, and create the largest venture of its kind in Europe. Globally, Discovery’s clinical network will grow by more than 100 sites, to nearly 280, allowing the company to offer the world’s largest repository of biospecimens.
“Sofia and East West Bio are highly regarded suppliers in the region and have been long-standing Discovery partners; they provide timely and high-quality services in compliance with all consent and industry regulations,” … “As we knit this territory together, we will streamline logistics and further invest in providing outstanding processing and analytic services to the global medical research community.”
“Eastern Europe’s clinical, academic, and research communities are seeking expanded opportunities to participate in the rapid growth of research and development of new diagnostics and therapies.” … “Discovery’s expansion will answer that need.” – Discovery’s CEO Glenn Bilawsky